Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Mar 12:13:RP95823.
doi: 10.7554/eLife.95823.

Using normative models pre-trained on cross-sectional data to evaluate intra-individual longitudinal changes in neuroimaging data

Affiliations

Using normative models pre-trained on cross-sectional data to evaluate intra-individual longitudinal changes in neuroimaging data

Barbora Rehak Buckova et al. Elife. .

Abstract

Longitudinal neuroimaging studies offer valuable insight into brain development, ageing, and disease progression over time. However, prevailing analytical approaches rooted in our understanding of population variation are primarily tailored for cross-sectional studies. To fully leverage the potential of longitudinal neuroimaging, we need methodologies that account for the complex interplay between population variation and individual dynamics. We extend the normative modelling framework, which evaluates an individual's position relative to population standards, to assess an individual's longitudinal change compared to the population's standard dynamics. Using normative models pre-trained on over 58,000 individuals, we introduce a quantitative metric termed 'z-diff' score, which quantifies a temporal change in individuals compared to a population standard. This approach offers advantages in flexibility in dataset size and ease of implementation. We applied this framework to a longitudinal dataset of 98 patients with early-stage schizophrenia who underwent MRI examinations shortly after diagnosis and 1 year later. Compared to cross-sectional analyses, showing global thinning of grey matter at the first visit, our method revealed a significant normalisation of grey matter thickness in the frontal lobe over time-an effect undetected by traditional longitudinal methods. Overall, our framework presents a flexible and effective methodology for analysing longitudinal neuroimaging data, providing insights into the progression of a disease that would otherwise be missed when using more traditional approaches.

Keywords: MRI; human; neuroimaging; neuroscience; normative modelling; psychosis; schizophrenia.

PubMed Disclaimer

Conflict of interest statement

BR, CF, RR, MK, CB, FŠ, JH No competing interests declared, AM Reviewing editor, eLife

Figures

Figure 1.
Figure 1.. Visualisations of the core assumptions of normative modelling.
(A) The parameters of the fitted normative model are independent of the time of sampling. (B) People of the same age are comparable irrespective of their year of birth (datasets sampled at different times can be combined).
Figure 2.
Figure 2.. Simulated detection rate of a true disruption Δ for various values of autocorrelation ρ (individual subplots) comparing the performance of our z-diff method against the naïve subtraction of z-scores.
The right column highlights the false-positive rate across various degrees of autocorrelation for the two approaches. We use σ2=1 and θ = 0.05.
Figure 3.
Figure 3.. The overview of the analytical pipeline for our schizophrenia patients: First, data are preprocessed using FreeSurfer’s longitudinal pipeline.
Subsequently, the pre-trained models are adjusted to a local sample of healthy controls. The site-specific measurement noise variance σξ2 in healthy subjects is estimated using held-out controls, and finally, the z-diff score is computed.
Figure 4.
Figure 4.. The effect of preprocessing across all subjects and image-derived phenotypes (IDPs).
(A) Cross-sectional preprocessing: Heatmap of the difference of the original z-scores (z(2)z(1)) on held-out controls. (B) Longitudinal preprocessing: Heatmap of the difference of the original z-scores (z(2)z(1)) on held-out controls. (C) Histogram of the average (z) across all IDPs stratified by health status and preprocessing. (D) Histogram of the average (z(2)z(1)) of each subject stratified by health status and preprocessing.
Figure 5.
Figure 5.. Cross-sectional results for each visit separately: p-Values of Mann-Whitney U test between patients and held-out controls surviving Benjamini-Hochberg correction.
The sign indicates the direction of change (negative means lower thickness in patients).
Figure 6.
Figure 6.. Regions significantly changed between the visits: Map of regions significantly changed between the two visits (centre).
Each region is described using a scatter plot of z-scores across all patients for both visits (the x-axis describes age and the y-axis depicts the z-score. Blue dots represent the first and pink dots represent the second visit). The grey dashed line highlights z = 0. Histograms in the golden circles depict the distribution of the z-diff score.
Figure 7.
Figure 7.. Results of the PCA.
(A) Scree plot of the explained variance of PCA components. (B) Scatter plot of change in the Global Assessment of Functioning (GAF) scale vs. the change in the Positive and Negative Syndrome Scale (PANSS) scale. (C, left) Scatter plot of the first PCA component and difference in the GAF scale. (C, right) Heatmap of PCA loadings for the first component. (D, left) Scatter plot of the second PCA component and difference in the PANSS scale. (D, right) A heatmap of PCA loadings for the second component. (E) Average z-diff score.
Appendix 2—figure 1.
Appendix 2—figure 1.. ρ^ estimates derived from the data.
Appendix 3—figure 1.
Appendix 3—figure 1.. Probability of detecting a true disruption Δ for various values of autocorrelation ρ (rows) and variances σ2 (columns) comparing the performance of our z-diff method against the naïve subtraction of z-scores.
We use θ = 0.05.
Appendix 4—figure 1.
Appendix 4—figure 1.. Quality of fit as measured by Rho for the first and the second visit.
Appendix 5—figure 1.
Appendix 5—figure 1.. Regions significantly changed between the visits (longitudinal preprocessing): Map of regions significantly changed between the two visits (centre).
Each region is described using a scatter plot of z-diff across all patients for both visits (the x-axis describes age and the y-axis depicts the z-diff. Blue dots represent individual patients and the pink line shows a trend of z-diff change). The grey dashed line highlights z=0. Histograms in the golden circles depict the distribution of the z-diff score.
Appendix 5—figure 2.
Appendix 5—figure 2.. Regions significantly changed between the visits (cross-sectional preprocessing): Map of regions significantly changed between the two visits (centre).
Each region is described using a scatter plot of z-diff scores across all patients for both visits (the x-axis describes age and the y-axis depicts the z-diff score). The grey dashed line highlights z=0. Histograms in the golden circles depict the distribution of the z-diff score.
Appendix 5—figure 3.
Appendix 5—figure 3.. Raw changes in grey matter thickness: Each significantly changed region is presented twice, once as a scatter plot containing the original grey matter thickness for both visits (left); females are plotted in pink, males in blue.
The figure on the right depicts visit 2 minus visit 1 in raw thicknesses (separately for females—pink, and males—blue).

Update of

  • doi: 10.1101/2023.06.09.544217
  • doi: 10.7554/eLife.95823.1
  • doi: 10.7554/eLife.95823.2
  • doi: 10.7554/eLife.95823.3

References

    1. Berthet P, Haatveit BC, Kjelkenes R, Worker A, Kia SM, Wolfers T, Rutherford S, Alnaes D, Dinga R, Pedersen ML, Dahl A, Fernandez-Cabello S, Dazzan P, Agartz I, Nesvåg R, Ueland T, Andreassen OA, Simonsen C, Westlye LT, Melle I, Marquand A. A 10-year longitudinal study of brain cortical thickness in people with first-episode psychosis using normative models. Schizophrenia Bulletin. 2024;51:95–107. doi: 10.1093/schbul/sbae107. - DOI - PMC - PubMed
    1. Bethlehem RAI, Seidlitz J, White SR, Vogel JW, Anderson KM, Adamson C, Adler S, Alexopoulos GS, Anagnostou E, Areces-Gonzalez A, Astle DE, Auyeung B, Ayub M, Bae J, Ball G, Baron-Cohen S, Beare R, Bedford SA, Benegal V, Beyer F, Blangero J, Blesa Cábez M, Boardman JP, Borzage M, Bosch-Bayard JF, Bourke N, Calhoun VD, Chakravarty MM, Chen C, Chertavian C, Chetelat G, Chong YS, Cole JH, Corvin A, Costantino M, Courchesne E, Crivello F, Cropley VL, Crosbie J, Crossley N, Delarue M, Delorme R, Desrivieres S, Devenyi GA, Di Biase MA, Dolan R, Donald KA, Donohoe G, Dunlop K, Edwards AD, Elison JT, Ellis CT, Elman JA, Eyler L, Fair DA, Feczko E, Fletcher PC, Fonagy P, Franz CE, Galan-Garcia L, Gholipour A, Giedd J, Gilmore JH, Glahn DC, Goodyer IM, Grant PE, Groenewold NA, Gunning FM, Gur RE, Gur RC, Hammill CF, Hansson O, Hedden T, Heinz A, Henson RN, Heuer K, Hoare J, Holla B, Holmes AJ, Holt R, Huang H, Im K, Ipser J, Jack CR, Jr, Jackowski AP, Jia T, Johnson KA, Jones PB, Jones DT, Kahn RS, Karlsson H, Karlsson L, Kawashima R, Kelley EA, Kern S, Kim KW, Kitzbichler MG, Kremen WS, Lalonde F, Landeau B, Lee S, Lerch J, Lewis JD, Li J, Liao W, Liston C, Lombardo MV, Lv J, Lynch C, Mallard TT, Marcelis M, Markello RD, Mathias SR, Mazoyer B, McGuire P, Meaney MJ, Mechelli A, Medic N, Misic B, Morgan SE, Mothersill D, Nigg J, Ong MQW, Ortinau C, Ossenkoppele R, Ouyang M, Palaniyappan L, Paly L, Pan PM, Pantelis C, Park MM, Paus T, Pausova Z, Paz-Linares D, Pichet Binette A, Pierce K, Qian X, Qiu J, Qiu A, Raznahan A, Rittman T, Rodrigue A, Rollins CK, Romero-Garcia R, Ronan L, Rosenberg MD, Rowitch DH, Salum GA, Satterthwaite TD, Schaare HL, Schachar RJ, Schultz AP, Schumann G, Schöll M, Sharp D, Shinohara RT, Skoog I, Smyser CD, Sperling RA, Stein DJ, Stolicyn A, Suckling J, Sullivan G, Taki Y, Thyreau B, Toro R, Traut N, Tsvetanov KA, Tuulari JJ, Tzourio C, Vachon-Presseau É, Valdes-Sosa MJ, Valdes-Sosa PA, Valk SL, van Amelsvoort T, Vandekar SN, Vasung L, Victoria LW, Villeneuve S, Villringer A, Vértes PE, Wagstyl K, Wang YS, Warfield SK, Warrier V, Westman E, Westwater ML, Whalley HC, Witte AV, Yang N, Yeo B, Yun H, Zalesky A, Zar HJ, Zettergren A, Zhou JH, Ziauddeen H, Zugman A, Zuo XN, Bullmore ET, Alexander-Bloch AF, 3R-BRAIN. AIBL. Alzheimer’s Disease Neuroimaging Initiative. Alzheimer’s Disease Repository Without Borders Investigators. CALM Team. Cam-CAN. CCNP. COBRE. cVEDA. ENIGMA Developmental Brain Age Working Group. Developing Human Connectome Project. FinnBrain. Harvard Aging Brain Study. IMAGEN. KNE96. Mayo Clinic Study of Aging. NSPN. POND. PREVENT-AD Research Group. VETSA Brain charts for the human lifespan. Nature. 2022;604:525–533. doi: 10.1038/s41586-022-04554-y. - DOI - PMC - PubMed
    1. Canal-Rivero M, Ruiz-Veguilla M, Ortiz-García de la Foz V, López-Díaz A, Garrido-Torres N, Ayesa-Arriola R, Vazquez-Bourgon J, Mayoral-van Son J, Brambilla P, Kircher T, Romero-García R, Crespo-Facorro B. Longitudinal trajectories in negative symptoms and changes in brain cortical thickness: 10-year follow-up study. The British Journal of Psychiatry. 2023;223:309–318. doi: 10.1192/bjp.2022.192. - DOI - PMC - PubMed
    1. Casey BJ, Cannonier T, Conley MI, Cohen AO, Barch DM, Heitzeg MM, Soules ME, Teslovich T, Dellarco DV, Garavan H, Orr CA, Wager TD, Banich MT, Speer NK, Sutherland MT, Riedel MC, Dick AS, Bjork JM, Thomas KM, Chaarani B, Mejia MH, Hagler DJ, Daniela Cornejo M, Sicat CS, Harms MP, Dosenbach NUF, Rosenberg M, Earl E, Bartsch H, Watts R, Polimeni JR, Kuperman JM, Fair DA, Dale AM. The adolescent brain cognitive development (ABCD) study: imaging acquisition across 21 sites. Developmental Cognitive Neuroscience. 2018;32:43–54. doi: 10.1016/j.dcn.2018.03.001. - DOI - PMC - PubMed
    1. Cole TJ. The development of growth references and growth charts. Annals of Human Biology. 2012;39:382–394. doi: 10.3109/03014460.2012.694475. - DOI - PMC - PubMed